Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Grasping the Basics of Business Land Regulation - 2Merz: 80% of Syrians in Germany should return in three years
- 3From Educational Loans to Obligation Free: Independence from the rat race Accomplished
- 44 Creative Savvy Home Gadgets of 2024: Reforming Home Robotization and Security
- 5I watched the buzzy new AI documentary — and left feeling both hopeful and terrified
- The Best Internet based Courses for Expertise Improvement
- Employers and staff feel effect of fuel price rise
- 23 Most Amusing Messages At any point Sent Among Kids and Their Folks
- How many ships have been attacked in the Gulf since start of Iran war?
- Inflammatory Merz remarks on migrants' violence against women slammed
- German hauliers warn soaring energy prices may soon impact consumers
- Famous Versatile Brands: Your Decision
- Hamas urges Hezbollah to kidnap Israeli soldiers in wake of Knesset passing death penalty bill
- Changing Negative Cash Mentalities: Enabling Your Monetary Excursion
